Researchers at St. Jude Children’s Research Hospital tirelessly and brilliantly work to advance cures for, and prevent, pediatric catastrophic diseases through research and treatment; and in their work they make discoveries beyond our core mission.

These discoveries require further development, so our office endeavors to license them to companies who will turn them into successful products. Here are just a few examples of discoveries licensed from St. Jude that have been incorporated into products or processes that are now deployed in the marketplace.

campus-exterior-eastern-side

Related Topics

More Technologies

In the News

St. Jude
Discovery aided quest for adult cancer drug

Reuters
Pfizer lung cancer drug beats chemo for previously untreated patients

Wall Street Journal
Novartis Drug Shows Promise in Rare Lung Cancer

BioSpace
Novartis AG (NVS) Gains FDA Approval For Lung Cancer Drug Zykadia

Xalkori® is now being tested in pediatric cancers, such as neuroblastoma and Anaplastic large cell lymphoma (ALCL), the population where the ALK gene was first discovered, bringing the discovery full circle:
Crizotinib Targets ALK-Driven Cancers in Pediatric Trial